Pharma & Healthcare
Global Budesonide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- May 05, 25
- ID: 222984
- Pages: 99
- Figures: 94
- Views: 43
The global Budesonide market size was US$ 8732 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn"s disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.
The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.
The global Budesonide market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
AstraZeneca
Teva
Mylan
Sandoz
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod
By Type: (Dominant Segment vs High-Margin Innovation)
Injectable Suspension
Aerosols
Inhalation Powder
Tablet and Capsule
By Application: (Core Demand Driver vs Emerging Opportunity)
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., AstraZeneca in Europe)
- Emerging Product Trends: Injectable Suspension adoption vs. Aerosols premiumization
- Demand-Side Dynamics: Respiratory Disease Treatment growth in China vs. Nose Disease Treatment potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Israel
China Taiwan
India
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Budesonide market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Aerosols in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Nose Disease Treatment in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Injectable Suspension dominance in Europe vs. Aerosols demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn"s disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.
The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.
The global Budesonide market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
AstraZeneca
Teva
Mylan
Sandoz
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod
By Type: (Dominant Segment vs High-Margin Innovation)
Injectable Suspension
Aerosols
Inhalation Powder
Tablet and Capsule
By Application: (Core Demand Driver vs Emerging Opportunity)
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., AstraZeneca in Europe)
- Emerging Product Trends: Injectable Suspension adoption vs. Aerosols premiumization
- Demand-Side Dynamics: Respiratory Disease Treatment growth in China vs. Nose Disease Treatment potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Israel
China Taiwan
India
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Budesonide market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Aerosols in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Nose Disease Treatment in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Injectable Suspension dominance in Europe vs. Aerosols demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Budesonide Product Scope
1.2 Budesonide by Type
1.2.1 Global Budesonide Sales by Type (2020 & 2024 & 2031)
1.2.2 Injectable Suspension
1.2.3 Aerosols
1.2.4 Inhalation Powder
1.2.5 Tablet and Capsule
1.3 Budesonide by Application
1.3.1 Global Budesonide Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Respiratory Disease Treatment
1.3.3 Nose Disease Treatment
1.3.4 Inflammatory Bowel Disease Treatment
1.3.5 Others
1.4 Global Budesonide Market Estimates and Forecasts (2020-2031)
1.4.1 Global Budesonide Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Budesonide Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Budesonide Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Budesonide Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Budesonide Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Budesonide Sales Market Share by Region (2020-2025)
2.2.2 Global Budesonide Revenue Market Share by Region (2020-2025)
2.3 Global Budesonide Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Budesonide Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Budesonide Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Budesonide Market Size and Prospective (2020-2031)
2.4.2 Europe Budesonide Market Size and Prospective (2020-2031)
2.4.3 China Budesonide Market Size and Prospective (2020-2031)
2.4.4 Israel Budesonide Market Size and Prospective (2020-2031)
2.4.5 China Taiwan Budesonide Market Size and Prospective (2020-2031)
2.4.6 India Budesonide Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Budesonide Historic Market Review by Type (2020-2025)
3.1.1 Global Budesonide Sales by Type (2020-2025)
3.1.2 Global Budesonide Revenue by Type (2020-2025)
3.1.3 Global Budesonide Price by Type (2020-2025)
3.2 Global Budesonide Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Budesonide Sales Forecast by Type (2026-2031)
3.2.2 Global Budesonide Revenue Forecast by Type (2026-2031)
3.2.3 Global Budesonide Price Forecast by Type (2026-2031)
3.3 Different Types Budesonide Representative Players
4 Global Market Size by Application
4.1 Global Budesonide Historic Market Review by Application (2020-2025)
4.1.1 Global Budesonide Sales by Application (2020-2025)
4.1.2 Global Budesonide Revenue by Application (2020-2025)
4.1.3 Global Budesonide Price by Application (2020-2025)
4.2 Global Budesonide Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Budesonide Sales Forecast by Application (2026-2031)
4.2.2 Global Budesonide Revenue Forecast by Application (2026-2031)
4.2.3 Global Budesonide Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Budesonide Application
5 Competition Landscape by Players
5.1 Global Budesonide Sales by Players (2020-2025)
5.2 Global Top Budesonide Players by Revenue (2020-2025)
5.3 Global Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Budesonide as of 2024)
5.4 Global Budesonide Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Budesonide, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Budesonide, Product Type & Application
5.7 Global Key Manufacturers of Budesonide, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Budesonide Sales by Company
6.1.1.1 North America Budesonide Sales by Company (2020-2025)
6.1.1.2 North America Budesonide Revenue by Company (2020-2025)
6.1.2 North America Budesonide Sales Breakdown by Type (2020-2025)
6.1.3 North America Budesonide Sales Breakdown by Application (2020-2025)
6.1.4 North America Budesonide Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Budesonide Sales by Company
6.2.1.1 Europe Budesonide Sales by Company (2020-2025)
6.2.1.2 Europe Budesonide Revenue by Company (2020-2025)
6.2.2 Europe Budesonide Sales Breakdown by Type (2020-2025)
6.2.3 Europe Budesonide Sales Breakdown by Application (2020-2025)
6.2.4 Europe Budesonide Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Budesonide Sales by Company
6.3.1.1 China Budesonide Sales by Company (2020-2025)
6.3.1.2 China Budesonide Revenue by Company (2020-2025)
6.3.2 China Budesonide Sales Breakdown by Type (2020-2025)
6.3.3 China Budesonide Sales Breakdown by Application (2020-2025)
6.3.4 China Budesonide Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Israel Market: Players, Segments, Downstream and Major Customers
6.4.1 Israel Budesonide Sales by Company
6.4.1.1 Israel Budesonide Sales by Company (2020-2025)
6.4.1.2 Israel Budesonide Revenue by Company (2020-2025)
6.4.2 Israel Budesonide Sales Breakdown by Type (2020-2025)
6.4.3 Israel Budesonide Sales Breakdown by Application (2020-2025)
6.4.4 Israel Budesonide Major Customer
6.4.5 Israel Market Trend and Opportunities
6.5 China Taiwan Market: Players, Segments, Downstream and Major Customers
6.5.1 China Taiwan Budesonide Sales by Company
6.5.1.1 China Taiwan Budesonide Sales by Company (2020-2025)
6.5.1.2 China Taiwan Budesonide Revenue by Company (2020-2025)
6.5.2 China Taiwan Budesonide Sales Breakdown by Type (2020-2025)
6.5.3 China Taiwan Budesonide Sales Breakdown by Application (2020-2025)
6.5.4 China Taiwan Budesonide Major Customer
6.5.5 China Taiwan Market Trend and Opportunities
6.6 India Market: Players, Segments, Downstream and Major Customers
6.6.1 India Budesonide Sales by Company
6.6.1.1 India Budesonide Sales by Company (2020-2025)
6.6.1.2 India Budesonide Revenue by Company (2020-2025)
6.6.2 India Budesonide Sales Breakdown by Type (2020-2025)
6.6.3 India Budesonide Sales Breakdown by Application (2020-2025)
6.6.4 India Budesonide Major Customer
6.6.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 AstraZeneca
7.1.1 AstraZeneca Company Information
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Budesonide Sales, Revenue and Gross Margin (2020-2025)
7.1.4 AstraZeneca Budesonide Products Offered
7.1.5 AstraZeneca Recent Development
7.2 Teva
7.2.1 Teva Company Information
7.2.2 Teva Business Overview
7.2.3 Teva Budesonide Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Teva Budesonide Products Offered
7.2.5 Teva Recent Development
7.3 Mylan
7.3.1 Mylan Company Information
7.3.2 Mylan Business Overview
7.3.3 Mylan Budesonide Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Mylan Budesonide Products Offered
7.3.5 Mylan Recent Development
7.4 Sandoz
7.4.1 Sandoz Company Information
7.4.2 Sandoz Business Overview
7.4.3 Sandoz Budesonide Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Sandoz Budesonide Products Offered
7.4.5 Sandoz Recent Development
7.5 Cosmo Pharmaceuticals
7.5.1 Cosmo Pharmaceuticals Company Information
7.5.2 Cosmo Pharmaceuticals Business Overview
7.5.3 Cosmo Pharmaceuticals Budesonide Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Cosmo Pharmaceuticals Budesonide Products Offered
7.5.5 Cosmo Pharmaceuticals Recent Development
7.6 Salix
7.6.1 Salix Company Information
7.6.2 Salix Business Overview
7.6.3 Salix Budesonide Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Salix Budesonide Products Offered
7.6.5 Salix Recent Development
7.7 Chiesi Farmaceutici
7.7.1 Chiesi Farmaceutici Company Information
7.7.2 Chiesi Farmaceutici Business Overview
7.7.3 Chiesi Farmaceutici Budesonide Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Chiesi Farmaceutici Budesonide Products Offered
7.7.5 Chiesi Farmaceutici Recent Development
7.8 Orion Corporation
7.8.1 Orion Corporation Company Information
7.8.2 Orion Corporation Business Overview
7.8.3 Orion Corporation Budesonide Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Orion Corporation Budesonide Products Offered
7.8.5 Orion Corporation Recent Development
7.9 Cipla
7.9.1 Cipla Company Information
7.9.2 Cipla Business Overview
7.9.3 Cipla Budesonide Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Cipla Budesonide Products Offered
7.9.5 Cipla Recent Development
7.10 Synmosa Biopharma
7.10.1 Synmosa Biopharma Company Information
7.10.2 Synmosa Biopharma Business Overview
7.10.3 Synmosa Biopharma Budesonide Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Synmosa Biopharma Budesonide Products Offered
7.10.5 Synmosa Biopharma Recent Development
7.11 Lunan Better Pharma
7.11.1 Lunan Better Pharma Company Information
7.11.2 Lunan Better Pharma Business Overview
7.11.3 Lunan Better Pharma Budesonide Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Lunan Better Pharma Budesonide Products Offered
7.11.5 Lunan Better Pharma Recent Development
7.12 Shanghai Sine Promod
7.12.1 Shanghai Sine Promod Company Information
7.12.2 Shanghai Sine Promod Business Overview
7.12.3 Shanghai Sine Promod Budesonide Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Shanghai Sine Promod Budesonide Products Offered
7.12.5 Shanghai Sine Promod Recent Development
8 Budesonide Manufacturing Cost Analysis
8.1 Budesonide Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Budesonide
8.4 Budesonide Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Budesonide Distributors List
9.3 Budesonide Customers
10 Budesonide Market Dynamics
10.1 Budesonide Industry Trends
10.2 Budesonide Market Drivers
10.3 Budesonide Market Challenges
10.4 Budesonide Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Budesonide Product Scope
1.2 Budesonide by Type
1.2.1 Global Budesonide Sales by Type (2020 & 2024 & 2031)
1.2.2 Injectable Suspension
1.2.3 Aerosols
1.2.4 Inhalation Powder
1.2.5 Tablet and Capsule
1.3 Budesonide by Application
1.3.1 Global Budesonide Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Respiratory Disease Treatment
1.3.3 Nose Disease Treatment
1.3.4 Inflammatory Bowel Disease Treatment
1.3.5 Others
1.4 Global Budesonide Market Estimates and Forecasts (2020-2031)
1.4.1 Global Budesonide Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Budesonide Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Budesonide Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Budesonide Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Budesonide Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Budesonide Sales Market Share by Region (2020-2025)
2.2.2 Global Budesonide Revenue Market Share by Region (2020-2025)
2.3 Global Budesonide Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Budesonide Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Budesonide Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Budesonide Market Size and Prospective (2020-2031)
2.4.2 Europe Budesonide Market Size and Prospective (2020-2031)
2.4.3 China Budesonide Market Size and Prospective (2020-2031)
2.4.4 Israel Budesonide Market Size and Prospective (2020-2031)
2.4.5 China Taiwan Budesonide Market Size and Prospective (2020-2031)
2.4.6 India Budesonide Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Budesonide Historic Market Review by Type (2020-2025)
3.1.1 Global Budesonide Sales by Type (2020-2025)
3.1.2 Global Budesonide Revenue by Type (2020-2025)
3.1.3 Global Budesonide Price by Type (2020-2025)
3.2 Global Budesonide Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Budesonide Sales Forecast by Type (2026-2031)
3.2.2 Global Budesonide Revenue Forecast by Type (2026-2031)
3.2.3 Global Budesonide Price Forecast by Type (2026-2031)
3.3 Different Types Budesonide Representative Players
4 Global Market Size by Application
4.1 Global Budesonide Historic Market Review by Application (2020-2025)
4.1.1 Global Budesonide Sales by Application (2020-2025)
4.1.2 Global Budesonide Revenue by Application (2020-2025)
4.1.3 Global Budesonide Price by Application (2020-2025)
4.2 Global Budesonide Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Budesonide Sales Forecast by Application (2026-2031)
4.2.2 Global Budesonide Revenue Forecast by Application (2026-2031)
4.2.3 Global Budesonide Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Budesonide Application
5 Competition Landscape by Players
5.1 Global Budesonide Sales by Players (2020-2025)
5.2 Global Top Budesonide Players by Revenue (2020-2025)
5.3 Global Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Budesonide as of 2024)
5.4 Global Budesonide Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Budesonide, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Budesonide, Product Type & Application
5.7 Global Key Manufacturers of Budesonide, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Budesonide Sales by Company
6.1.1.1 North America Budesonide Sales by Company (2020-2025)
6.1.1.2 North America Budesonide Revenue by Company (2020-2025)
6.1.2 North America Budesonide Sales Breakdown by Type (2020-2025)
6.1.3 North America Budesonide Sales Breakdown by Application (2020-2025)
6.1.4 North America Budesonide Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Budesonide Sales by Company
6.2.1.1 Europe Budesonide Sales by Company (2020-2025)
6.2.1.2 Europe Budesonide Revenue by Company (2020-2025)
6.2.2 Europe Budesonide Sales Breakdown by Type (2020-2025)
6.2.3 Europe Budesonide Sales Breakdown by Application (2020-2025)
6.2.4 Europe Budesonide Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Budesonide Sales by Company
6.3.1.1 China Budesonide Sales by Company (2020-2025)
6.3.1.2 China Budesonide Revenue by Company (2020-2025)
6.3.2 China Budesonide Sales Breakdown by Type (2020-2025)
6.3.3 China Budesonide Sales Breakdown by Application (2020-2025)
6.3.4 China Budesonide Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Israel Market: Players, Segments, Downstream and Major Customers
6.4.1 Israel Budesonide Sales by Company
6.4.1.1 Israel Budesonide Sales by Company (2020-2025)
6.4.1.2 Israel Budesonide Revenue by Company (2020-2025)
6.4.2 Israel Budesonide Sales Breakdown by Type (2020-2025)
6.4.3 Israel Budesonide Sales Breakdown by Application (2020-2025)
6.4.4 Israel Budesonide Major Customer
6.4.5 Israel Market Trend and Opportunities
6.5 China Taiwan Market: Players, Segments, Downstream and Major Customers
6.5.1 China Taiwan Budesonide Sales by Company
6.5.1.1 China Taiwan Budesonide Sales by Company (2020-2025)
6.5.1.2 China Taiwan Budesonide Revenue by Company (2020-2025)
6.5.2 China Taiwan Budesonide Sales Breakdown by Type (2020-2025)
6.5.3 China Taiwan Budesonide Sales Breakdown by Application (2020-2025)
6.5.4 China Taiwan Budesonide Major Customer
6.5.5 China Taiwan Market Trend and Opportunities
6.6 India Market: Players, Segments, Downstream and Major Customers
6.6.1 India Budesonide Sales by Company
6.6.1.1 India Budesonide Sales by Company (2020-2025)
6.6.1.2 India Budesonide Revenue by Company (2020-2025)
6.6.2 India Budesonide Sales Breakdown by Type (2020-2025)
6.6.3 India Budesonide Sales Breakdown by Application (2020-2025)
6.6.4 India Budesonide Major Customer
6.6.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 AstraZeneca
7.1.1 AstraZeneca Company Information
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Budesonide Sales, Revenue and Gross Margin (2020-2025)
7.1.4 AstraZeneca Budesonide Products Offered
7.1.5 AstraZeneca Recent Development
7.2 Teva
7.2.1 Teva Company Information
7.2.2 Teva Business Overview
7.2.3 Teva Budesonide Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Teva Budesonide Products Offered
7.2.5 Teva Recent Development
7.3 Mylan
7.3.1 Mylan Company Information
7.3.2 Mylan Business Overview
7.3.3 Mylan Budesonide Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Mylan Budesonide Products Offered
7.3.5 Mylan Recent Development
7.4 Sandoz
7.4.1 Sandoz Company Information
7.4.2 Sandoz Business Overview
7.4.3 Sandoz Budesonide Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Sandoz Budesonide Products Offered
7.4.5 Sandoz Recent Development
7.5 Cosmo Pharmaceuticals
7.5.1 Cosmo Pharmaceuticals Company Information
7.5.2 Cosmo Pharmaceuticals Business Overview
7.5.3 Cosmo Pharmaceuticals Budesonide Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Cosmo Pharmaceuticals Budesonide Products Offered
7.5.5 Cosmo Pharmaceuticals Recent Development
7.6 Salix
7.6.1 Salix Company Information
7.6.2 Salix Business Overview
7.6.3 Salix Budesonide Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Salix Budesonide Products Offered
7.6.5 Salix Recent Development
7.7 Chiesi Farmaceutici
7.7.1 Chiesi Farmaceutici Company Information
7.7.2 Chiesi Farmaceutici Business Overview
7.7.3 Chiesi Farmaceutici Budesonide Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Chiesi Farmaceutici Budesonide Products Offered
7.7.5 Chiesi Farmaceutici Recent Development
7.8 Orion Corporation
7.8.1 Orion Corporation Company Information
7.8.2 Orion Corporation Business Overview
7.8.3 Orion Corporation Budesonide Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Orion Corporation Budesonide Products Offered
7.8.5 Orion Corporation Recent Development
7.9 Cipla
7.9.1 Cipla Company Information
7.9.2 Cipla Business Overview
7.9.3 Cipla Budesonide Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Cipla Budesonide Products Offered
7.9.5 Cipla Recent Development
7.10 Synmosa Biopharma
7.10.1 Synmosa Biopharma Company Information
7.10.2 Synmosa Biopharma Business Overview
7.10.3 Synmosa Biopharma Budesonide Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Synmosa Biopharma Budesonide Products Offered
7.10.5 Synmosa Biopharma Recent Development
7.11 Lunan Better Pharma
7.11.1 Lunan Better Pharma Company Information
7.11.2 Lunan Better Pharma Business Overview
7.11.3 Lunan Better Pharma Budesonide Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Lunan Better Pharma Budesonide Products Offered
7.11.5 Lunan Better Pharma Recent Development
7.12 Shanghai Sine Promod
7.12.1 Shanghai Sine Promod Company Information
7.12.2 Shanghai Sine Promod Business Overview
7.12.3 Shanghai Sine Promod Budesonide Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Shanghai Sine Promod Budesonide Products Offered
7.12.5 Shanghai Sine Promod Recent Development
8 Budesonide Manufacturing Cost Analysis
8.1 Budesonide Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Budesonide
8.4 Budesonide Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Budesonide Distributors List
9.3 Budesonide Customers
10 Budesonide Market Dynamics
10.1 Budesonide Industry Trends
10.2 Budesonide Market Drivers
10.3 Budesonide Market Challenges
10.4 Budesonide Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Budesonide Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Budesonide Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Budesonide Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Budesonide Sales (M Units) by Region (2020-2025)
Table 5. Global Budesonide Sales Market Share by Region (2020-2025)
Table 6. Global Budesonide Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Budesonide Revenue Share by Region (2020-2025)
Table 8. Global Budesonide Sales (M Units) Forecast by Region (2026-2031)
Table 9. Global Budesonide Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Budesonide Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Budesonide Revenue Share Forecast by Region (2026-2031)
Table 12. Global Budesonide Sales by Type (M Units) & (2020-2025)
Table 13. Global Budesonide Sales Share by Type (2020-2025)
Table 14. Global Budesonide Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Budesonide Price by Type (USD/K Units) & (2020-2025)
Table 16. Global Budesonide Sales by Type (M Units) & (2026-2031)
Table 17. Global Budesonide Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Budesonide Price by Type (USD/K Units) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Budesonide Sales by Application (M Units) & (2020-2025)
Table 21. Global Budesonide Sales Share by Application (2020-2025)
Table 22. Global Budesonide Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Budesonide Price by Application (USD/K Units) & (2020-2025)
Table 24. Global Budesonide Sales by Application (M Units) & (2026-2031)
Table 25. Global Budesonide Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Budesonide Price by Application (USD/K Units) & (2026-2031)
Table 27. New Sources of Growth in Budesonide Application
Table 28. Global Budesonide Sales by Company (M Units) & (2020-2025)
Table 29. Global Budesonide Sales Share by Company (2020-2025)
Table 30. Global Budesonide Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Budesonide Revenue Share by Company (2020-2025)
Table 32. Global Budesonide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Budesonide as of 2024)
Table 33. Global Market Budesonide Average Price by Company (USD/K Units) & (2020-2025)
Table 34. Global Key Manufacturers of Budesonide, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Budesonide, Product Type & Application
Table 36. Global Key Manufacturers of Budesonide, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Budesonide Sales by Company (2020-2025) & (M Units)
Table 39. North America Budesonide Sales Market Share by Company (2020-2025)
Table 40. North America Budesonide Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Budesonide Revenue Market Share by Company (2020-2025)
Table 42. North America Budesonide Sales by Type (2020-2025) & (M Units)
Table 43. North America Budesonide Sales Market Share by Type (2020-2025)
Table 44. North America Budesonide Sales by Application (2020-2025) & (M Units)
Table 45. North America Budesonide Sales Market Share by Application (2020-2025)
Table 46. Europe Budesonide Sales by Company (2020-2025) & (M Units)
Table 47. Europe Budesonide Sales Market Share by Company (2020-2025)
Table 48. Europe Budesonide Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Budesonide Revenue Market Share by Company (2020-2025)
Table 50. Europe Budesonide Sales by Type (2020-2025) & (M Units)
Table 51. Europe Budesonide Sales Market Share by Type (2020-2025)
Table 52. Europe Budesonide Sales by Application (2020-2025) & (M Units)
Table 53. Europe Budesonide Sales Market Share by Application (2020-2025)
Table 54. China Budesonide Sales by Company (2020-2025) & (M Units)
Table 55. China Budesonide Sales Market Share by Company (2020-2025)
Table 56. China Budesonide Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Budesonide Revenue Market Share by Company (2020-2025)
Table 58. China Budesonide Sales by Type (2020-2025) & (M Units)
Table 59. China Budesonide Sales Market Share by Type (2020-2025)
Table 60. China Budesonide Sales by Application (2020-2025) & (M Units)
Table 61. China Budesonide Sales Market Share by Application (2020-2025)
Table 62. Israel Budesonide Sales by Company (2020-2025) & (M Units)
Table 63. Israel Budesonide Sales Market Share by Company (2020-2025)
Table 64. Israel Budesonide Revenue by Company (2020-2025) & (US$ Million)
Table 65. Israel Budesonide Revenue Market Share by Company (2020-2025)
Table 66. Israel Budesonide Sales by Type (2020-2025) & (M Units)
Table 67. Israel Budesonide Sales Market Share by Type (2020-2025)
Table 68. Israel Budesonide Sales by Application (2020-2025) & (M Units)
Table 69. Israel Budesonide Sales Market Share by Application (2020-2025)
Table 70. China Taiwan Budesonide Sales by Company (2020-2025) & (M Units)
Table 71. China Taiwan Budesonide Sales Market Share by Company (2020-2025)
Table 72. China Taiwan Budesonide Revenue by Company (2020-2025) & (US$ Million)
Table 73. China Taiwan Budesonide Revenue Market Share by Company (2020-2025)
Table 74. China Taiwan Budesonide Sales by Type (2020-2025) & (M Units)
Table 75. China Taiwan Budesonide Sales Market Share by Type (2020-2025)
Table 76. China Taiwan Budesonide Sales by Application (2020-2025) & (M Units)
Table 77. China Taiwan Budesonide Sales Market Share by Application (2020-2025)
Table 78. India Budesonide Sales by Company (2020-2025) & (M Units)
Table 79. India Budesonide Sales Market Share by Company (2020-2025)
Table 80. India Budesonide Revenue by Company (2020-2025) & (US$ Million)
Table 81. India Budesonide Revenue Market Share by Company (2020-2025)
Table 82. India Budesonide Sales by Type (2020-2025) & (M Units)
Table 83. India Budesonide Sales Market Share by Type (2020-2025)
Table 84. India Budesonide Sales by Application (2020-2025) & (M Units)
Table 85. India Budesonide Sales Market Share by Application (2020-2025)
Table 86. AstraZeneca Company Information
Table 87. AstraZeneca Description and Business Overview
Table 88. AstraZeneca Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 89. AstraZeneca Budesonide Product
Table 90. AstraZeneca Recent Development
Table 91. Teva Company Information
Table 92. Teva Description and Business Overview
Table 93. Teva Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 94. Teva Budesonide Product
Table 95. Teva Recent Development
Table 96. Mylan Company Information
Table 97. Mylan Description and Business Overview
Table 98. Mylan Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 99. Mylan Budesonide Product
Table 100. Mylan Recent Development
Table 101. Sandoz Company Information
Table 102. Sandoz Description and Business Overview
Table 103. Sandoz Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 104. Sandoz Budesonide Product
Table 105. Sandoz Recent Development
Table 106. Cosmo Pharmaceuticals Company Information
Table 107. Cosmo Pharmaceuticals Description and Business Overview
Table 108. Cosmo Pharmaceuticals Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 109. Cosmo Pharmaceuticals Budesonide Product
Table 110. Cosmo Pharmaceuticals Recent Development
Table 111. Salix Company Information
Table 112. Salix Description and Business Overview
Table 113. Salix Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 114. Salix Budesonide Product
Table 115. Salix Recent Development
Table 116. Chiesi Farmaceutici Company Information
Table 117. Chiesi Farmaceutici Description and Business Overview
Table 118. Chiesi Farmaceutici Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 119. Chiesi Farmaceutici Budesonide Product
Table 120. Chiesi Farmaceutici Recent Development
Table 121. Orion Corporation Company Information
Table 122. Orion Corporation Description and Business Overview
Table 123. Orion Corporation Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 124. Orion Corporation Budesonide Product
Table 125. Orion Corporation Recent Development
Table 126. Cipla Company Information
Table 127. Cipla Description and Business Overview
Table 128. Cipla Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 129. Cipla Budesonide Product
Table 130. Cipla Recent Development
Table 131. Synmosa Biopharma Company Information
Table 132. Synmosa Biopharma Description and Business Overview
Table 133. Synmosa Biopharma Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 134. Synmosa Biopharma Budesonide Product
Table 135. Synmosa Biopharma Recent Development
Table 136. Lunan Better Pharma Company Information
Table 137. Lunan Better Pharma Description and Business Overview
Table 138. Lunan Better Pharma Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 139. Lunan Better Pharma Budesonide Product
Table 140. Lunan Better Pharma Recent Development
Table 141. Shanghai Sine Promod Company Information
Table 142. Shanghai Sine Promod Description and Business Overview
Table 143. Shanghai Sine Promod Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 144. Shanghai Sine Promod Budesonide Product
Table 145. Shanghai Sine Promod Recent Development
Table 146. Production Base and Market Concentration Rate of Raw Material
Table 147. Key Suppliers of Raw Materials
Table 148. Budesonide Distributors List
Table 149. Budesonide Customers List
Table 150. Budesonide Market Trends
Table 151. Budesonide Market Drivers
Table 152. Budesonide Market Challenges
Table 153. Budesonide Market Restraints
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Budesonide Product Picture
Figure 2. Global Budesonide Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Budesonide Sales Market Share by Type in 2024 & 2031
Figure 4. Injectable Suspension Product Picture
Figure 5. Aerosols Product Picture
Figure 6. Inhalation Powder Product Picture
Figure 7. Tablet and Capsule Product Picture
Figure 8. Global Budesonide Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 9. Global Budesonide Sales Market Share by Application in 2024 & 2031
Figure 10. Respiratory Disease Treatment Examples
Figure 11. Nose Disease Treatment Examples
Figure 12. Inflammatory Bowel Disease Treatment Examples
Figure 13. Others Examples
Figure 14. Global Budesonide Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Budesonide Sales Growth Rate (2020-2031) & (US$ Million)
Figure 16. Global Budesonide Sales (M Units) Growth Rate (2020-2031)
Figure 17. Global Budesonide Price Trends Growth Rate (2020-2031) & (USD/K Units)
Figure 18. Budesonide Report Years Considered
Figure 19. Global Market Budesonide Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 20. Global Budesonide Revenue Market Share by Region: 2020 VS 2024
Figure 21. North America Budesonide Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. North America Budesonide Sales (M Units) Growth Rate (2020-2031)
Figure 23. Europe Budesonide Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. Europe Budesonide Sales (M Units) Growth Rate (2020-2031)
Figure 25. China Budesonide Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. China Budesonide Sales (M Units) Growth Rate (2020-2031)
Figure 27. Israel Budesonide Revenue (US$ Million) Growth Rate (2020-2031)
Figure 28. Israel Budesonide Sales (M Units) Growth Rate (2020-2031)
Figure 29. China Taiwan Budesonide Revenue (US$ Million) Growth Rate (2020-2031)
Figure 30. China Taiwan Budesonide Sales (M Units) Growth Rate (2020-2031)
Figure 31. India Budesonide Revenue (US$ Million) Growth Rate (2020-2031)
Figure 32. India Budesonide Sales (M Units) Growth Rate (2020-2031)
Figure 33. Global Budesonide Revenue Share by Type (2020-2025)
Figure 34. Global Budesonide Sales Share by Type (2026-2031)
Figure 35. Global Budesonide Revenue Share by Type (2026-2031)
Figure 36. Global Budesonide Revenue Share by Application (2020-2025)
Figure 37. Global Budesonide Revenue Growth Rate by Application in 2020 & 2024
Figure 38. Global Budesonide Sales Share by Application (2026-2031)
Figure 39. Global Budesonide Revenue Share by Application (2026-2031)
Figure 40. Global Budesonide Sales Share by Company (2024)
Figure 41. Global Budesonide Revenue Share by Company (2024)
Figure 42. Global 5 Largest Budesonide Players Market Share by Revenue in Budesonide: 2020 & 2024
Figure 43. Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 44. Manufacturing Cost Structure of Budesonide
Figure 45. Manufacturing Process Analysis of Budesonide
Figure 46. Budesonide Industrial Chain
Figure 47. Channels of Distribution (Direct Vs Distribution)
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Table 1. Global Budesonide Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Budesonide Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Budesonide Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Budesonide Sales (M Units) by Region (2020-2025)
Table 5. Global Budesonide Sales Market Share by Region (2020-2025)
Table 6. Global Budesonide Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Budesonide Revenue Share by Region (2020-2025)
Table 8. Global Budesonide Sales (M Units) Forecast by Region (2026-2031)
Table 9. Global Budesonide Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Budesonide Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Budesonide Revenue Share Forecast by Region (2026-2031)
Table 12. Global Budesonide Sales by Type (M Units) & (2020-2025)
Table 13. Global Budesonide Sales Share by Type (2020-2025)
Table 14. Global Budesonide Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Budesonide Price by Type (USD/K Units) & (2020-2025)
Table 16. Global Budesonide Sales by Type (M Units) & (2026-2031)
Table 17. Global Budesonide Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Budesonide Price by Type (USD/K Units) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Budesonide Sales by Application (M Units) & (2020-2025)
Table 21. Global Budesonide Sales Share by Application (2020-2025)
Table 22. Global Budesonide Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Budesonide Price by Application (USD/K Units) & (2020-2025)
Table 24. Global Budesonide Sales by Application (M Units) & (2026-2031)
Table 25. Global Budesonide Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Budesonide Price by Application (USD/K Units) & (2026-2031)
Table 27. New Sources of Growth in Budesonide Application
Table 28. Global Budesonide Sales by Company (M Units) & (2020-2025)
Table 29. Global Budesonide Sales Share by Company (2020-2025)
Table 30. Global Budesonide Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Budesonide Revenue Share by Company (2020-2025)
Table 32. Global Budesonide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Budesonide as of 2024)
Table 33. Global Market Budesonide Average Price by Company (USD/K Units) & (2020-2025)
Table 34. Global Key Manufacturers of Budesonide, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Budesonide, Product Type & Application
Table 36. Global Key Manufacturers of Budesonide, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Budesonide Sales by Company (2020-2025) & (M Units)
Table 39. North America Budesonide Sales Market Share by Company (2020-2025)
Table 40. North America Budesonide Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Budesonide Revenue Market Share by Company (2020-2025)
Table 42. North America Budesonide Sales by Type (2020-2025) & (M Units)
Table 43. North America Budesonide Sales Market Share by Type (2020-2025)
Table 44. North America Budesonide Sales by Application (2020-2025) & (M Units)
Table 45. North America Budesonide Sales Market Share by Application (2020-2025)
Table 46. Europe Budesonide Sales by Company (2020-2025) & (M Units)
Table 47. Europe Budesonide Sales Market Share by Company (2020-2025)
Table 48. Europe Budesonide Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Budesonide Revenue Market Share by Company (2020-2025)
Table 50. Europe Budesonide Sales by Type (2020-2025) & (M Units)
Table 51. Europe Budesonide Sales Market Share by Type (2020-2025)
Table 52. Europe Budesonide Sales by Application (2020-2025) & (M Units)
Table 53. Europe Budesonide Sales Market Share by Application (2020-2025)
Table 54. China Budesonide Sales by Company (2020-2025) & (M Units)
Table 55. China Budesonide Sales Market Share by Company (2020-2025)
Table 56. China Budesonide Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Budesonide Revenue Market Share by Company (2020-2025)
Table 58. China Budesonide Sales by Type (2020-2025) & (M Units)
Table 59. China Budesonide Sales Market Share by Type (2020-2025)
Table 60. China Budesonide Sales by Application (2020-2025) & (M Units)
Table 61. China Budesonide Sales Market Share by Application (2020-2025)
Table 62. Israel Budesonide Sales by Company (2020-2025) & (M Units)
Table 63. Israel Budesonide Sales Market Share by Company (2020-2025)
Table 64. Israel Budesonide Revenue by Company (2020-2025) & (US$ Million)
Table 65. Israel Budesonide Revenue Market Share by Company (2020-2025)
Table 66. Israel Budesonide Sales by Type (2020-2025) & (M Units)
Table 67. Israel Budesonide Sales Market Share by Type (2020-2025)
Table 68. Israel Budesonide Sales by Application (2020-2025) & (M Units)
Table 69. Israel Budesonide Sales Market Share by Application (2020-2025)
Table 70. China Taiwan Budesonide Sales by Company (2020-2025) & (M Units)
Table 71. China Taiwan Budesonide Sales Market Share by Company (2020-2025)
Table 72. China Taiwan Budesonide Revenue by Company (2020-2025) & (US$ Million)
Table 73. China Taiwan Budesonide Revenue Market Share by Company (2020-2025)
Table 74. China Taiwan Budesonide Sales by Type (2020-2025) & (M Units)
Table 75. China Taiwan Budesonide Sales Market Share by Type (2020-2025)
Table 76. China Taiwan Budesonide Sales by Application (2020-2025) & (M Units)
Table 77. China Taiwan Budesonide Sales Market Share by Application (2020-2025)
Table 78. India Budesonide Sales by Company (2020-2025) & (M Units)
Table 79. India Budesonide Sales Market Share by Company (2020-2025)
Table 80. India Budesonide Revenue by Company (2020-2025) & (US$ Million)
Table 81. India Budesonide Revenue Market Share by Company (2020-2025)
Table 82. India Budesonide Sales by Type (2020-2025) & (M Units)
Table 83. India Budesonide Sales Market Share by Type (2020-2025)
Table 84. India Budesonide Sales by Application (2020-2025) & (M Units)
Table 85. India Budesonide Sales Market Share by Application (2020-2025)
Table 86. AstraZeneca Company Information
Table 87. AstraZeneca Description and Business Overview
Table 88. AstraZeneca Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 89. AstraZeneca Budesonide Product
Table 90. AstraZeneca Recent Development
Table 91. Teva Company Information
Table 92. Teva Description and Business Overview
Table 93. Teva Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 94. Teva Budesonide Product
Table 95. Teva Recent Development
Table 96. Mylan Company Information
Table 97. Mylan Description and Business Overview
Table 98. Mylan Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 99. Mylan Budesonide Product
Table 100. Mylan Recent Development
Table 101. Sandoz Company Information
Table 102. Sandoz Description and Business Overview
Table 103. Sandoz Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 104. Sandoz Budesonide Product
Table 105. Sandoz Recent Development
Table 106. Cosmo Pharmaceuticals Company Information
Table 107. Cosmo Pharmaceuticals Description and Business Overview
Table 108. Cosmo Pharmaceuticals Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 109. Cosmo Pharmaceuticals Budesonide Product
Table 110. Cosmo Pharmaceuticals Recent Development
Table 111. Salix Company Information
Table 112. Salix Description and Business Overview
Table 113. Salix Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 114. Salix Budesonide Product
Table 115. Salix Recent Development
Table 116. Chiesi Farmaceutici Company Information
Table 117. Chiesi Farmaceutici Description and Business Overview
Table 118. Chiesi Farmaceutici Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 119. Chiesi Farmaceutici Budesonide Product
Table 120. Chiesi Farmaceutici Recent Development
Table 121. Orion Corporation Company Information
Table 122. Orion Corporation Description and Business Overview
Table 123. Orion Corporation Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 124. Orion Corporation Budesonide Product
Table 125. Orion Corporation Recent Development
Table 126. Cipla Company Information
Table 127. Cipla Description and Business Overview
Table 128. Cipla Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 129. Cipla Budesonide Product
Table 130. Cipla Recent Development
Table 131. Synmosa Biopharma Company Information
Table 132. Synmosa Biopharma Description and Business Overview
Table 133. Synmosa Biopharma Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 134. Synmosa Biopharma Budesonide Product
Table 135. Synmosa Biopharma Recent Development
Table 136. Lunan Better Pharma Company Information
Table 137. Lunan Better Pharma Description and Business Overview
Table 138. Lunan Better Pharma Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 139. Lunan Better Pharma Budesonide Product
Table 140. Lunan Better Pharma Recent Development
Table 141. Shanghai Sine Promod Company Information
Table 142. Shanghai Sine Promod Description and Business Overview
Table 143. Shanghai Sine Promod Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 144. Shanghai Sine Promod Budesonide Product
Table 145. Shanghai Sine Promod Recent Development
Table 146. Production Base and Market Concentration Rate of Raw Material
Table 147. Key Suppliers of Raw Materials
Table 148. Budesonide Distributors List
Table 149. Budesonide Customers List
Table 150. Budesonide Market Trends
Table 151. Budesonide Market Drivers
Table 152. Budesonide Market Challenges
Table 153. Budesonide Market Restraints
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Budesonide Product Picture
Figure 2. Global Budesonide Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Budesonide Sales Market Share by Type in 2024 & 2031
Figure 4. Injectable Suspension Product Picture
Figure 5. Aerosols Product Picture
Figure 6. Inhalation Powder Product Picture
Figure 7. Tablet and Capsule Product Picture
Figure 8. Global Budesonide Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 9. Global Budesonide Sales Market Share by Application in 2024 & 2031
Figure 10. Respiratory Disease Treatment Examples
Figure 11. Nose Disease Treatment Examples
Figure 12. Inflammatory Bowel Disease Treatment Examples
Figure 13. Others Examples
Figure 14. Global Budesonide Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Budesonide Sales Growth Rate (2020-2031) & (US$ Million)
Figure 16. Global Budesonide Sales (M Units) Growth Rate (2020-2031)
Figure 17. Global Budesonide Price Trends Growth Rate (2020-2031) & (USD/K Units)
Figure 18. Budesonide Report Years Considered
Figure 19. Global Market Budesonide Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 20. Global Budesonide Revenue Market Share by Region: 2020 VS 2024
Figure 21. North America Budesonide Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. North America Budesonide Sales (M Units) Growth Rate (2020-2031)
Figure 23. Europe Budesonide Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. Europe Budesonide Sales (M Units) Growth Rate (2020-2031)
Figure 25. China Budesonide Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. China Budesonide Sales (M Units) Growth Rate (2020-2031)
Figure 27. Israel Budesonide Revenue (US$ Million) Growth Rate (2020-2031)
Figure 28. Israel Budesonide Sales (M Units) Growth Rate (2020-2031)
Figure 29. China Taiwan Budesonide Revenue (US$ Million) Growth Rate (2020-2031)
Figure 30. China Taiwan Budesonide Sales (M Units) Growth Rate (2020-2031)
Figure 31. India Budesonide Revenue (US$ Million) Growth Rate (2020-2031)
Figure 32. India Budesonide Sales (M Units) Growth Rate (2020-2031)
Figure 33. Global Budesonide Revenue Share by Type (2020-2025)
Figure 34. Global Budesonide Sales Share by Type (2026-2031)
Figure 35. Global Budesonide Revenue Share by Type (2026-2031)
Figure 36. Global Budesonide Revenue Share by Application (2020-2025)
Figure 37. Global Budesonide Revenue Growth Rate by Application in 2020 & 2024
Figure 38. Global Budesonide Sales Share by Application (2026-2031)
Figure 39. Global Budesonide Revenue Share by Application (2026-2031)
Figure 40. Global Budesonide Sales Share by Company (2024)
Figure 41. Global Budesonide Revenue Share by Company (2024)
Figure 42. Global 5 Largest Budesonide Players Market Share by Revenue in Budesonide: 2020 & 2024
Figure 43. Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 44. Manufacturing Cost Structure of Budesonide
Figure 45. Manufacturing Process Analysis of Budesonide
Figure 46. Budesonide Industrial Chain
Figure 47. Channels of Distribution (Direct Vs Distribution)
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232